Gendron Marie-Eve, Thorin Eric, Perrault Louis P
Department of Surgery, Research Center, Institut de Cardiologie de Montréal, 5000, rue Bélanger, Montréal, Québec, Canada H1T 1C8.
Br J Pharmacol. 2004 Sep;143(2):285-91. doi: 10.1038/sj.bjp.0705937. Epub 2004 Aug 23.
The influence of left ventricular hypertrophy (LVH) on the endothelial function of resistance endocardial arteries is not well established. The aim of this study was to characterise the mechanisms responsible for UK-14,304 (alpha(2)-adrenoreceptor agonist)-induced endothelium-dependent dilation in pig endocardial arteries isolated from hearts with or without LVH. LVH was induced by aortic banding 2 months before determining endothelial function. Following euthanasia, hearts were harvested and endocardial resistance arteries were isolated and pressurised to 100 mmHg in no-flow conditions. Vessels were preconstricted with acetylcholine (ACh) or high external K(+) (40 mmol l(-1) KCl). Results are expressed as mean+/-s.e.m. UK-14,304 induced a maximal dilation representing 79+/-6% (n=8) of the maximal diameter. NO synthase (l-NNA, 10 micromol l(-1), n=7) or guanylate cyclase (ODQ, 10 micromol l(-1), n=4) inhibition reduced (P<0.05) UK-14,304-dependent dilation to 35+/-6 and 18+/-7%, respectively. Apamin and charybdotoxin reduced (P<0.05) to 39+/-8% (n=4) the dilation induced by UK-14,304. In depolarised conditions, however, this dilation was prevented (P<0.05). UK-14,304-induced dilation was reduced (P<0.05) by glibenclamide (Glib, 1 micromol l(-1)), a K(ATP) channel blocker, either alone (35+/-10%, n=5) or in combination with l-NNA (34+/-9%, n=4). In LVH, UK-14,304-induced maximal dilation was markedly reduced (25+/-4%, P<0.05) compared to control; it was insensitive to l-NNA (21+/-5%) but prevented either by the combination of l-NNA, apamin and charybdotoxin, or by 40 mmol l(-1) KCl. Activation of endothelial alpha(2)-adrenoreceptor induces an endothelium-dependent dilation of pig endocardial resistance arteries. This dilation is in part dependent on NO, the release of which appears to be dependent on the activation of endothelial K(ATP) channels. This mechanism is blunted in LVH, leading to a profound reduction in UK-14,304-dependent dilation.
左心室肥厚(LVH)对阻力性心内膜动脉内皮功能的影响尚未完全明确。本研究旨在阐明UK - 14,304(α₂ - 肾上腺素能受体激动剂)诱导的、来自有或无LVH心脏的猪心内膜动脉内皮依赖性舒张的机制。在测定内皮功能前2个月通过主动脉缩窄诱导LVH。安乐死后,取出心脏,分离心内膜阻力动脉,并在无血流条件下将压力升至100 mmHg。血管先用乙酰胆碱(ACh)或高浓度外钾(40 mmol/L KCl)预收缩。结果以平均值±标准误表示。UK - 14,304诱导的最大舒张幅度为最大直径的79±6%(n = 8)。一氧化氮合酶抑制剂(l - NNA,10 μmol/L,n = 7)或鸟苷酸环化酶抑制剂(ODQ,10 μmol/L,n = 4)可使UK - 14,304依赖性舒张分别降低至35±6%和18±7%(P < 0.05)。蜂毒明肽和蝎毒素可使UK - 14,304诱导的舒张降低至39±8%(n = 4)(P < 0.05)。然而,在去极化条件下,这种舒张被抑制(P < 0.05)。UK - 14,304诱导的舒张可被格列本脲(Glib,1 μmol/L)(一种KATP通道阻滞剂)单独(35±10%,n = 5)或与l - NNA联合(34±9%,n = 4)降低(P < 0.05)。在LVH组,与对照组相比,UK - 14,304诱导的最大舒张明显降低(25±4%,P < 0.05);它对l - NNA不敏感(21±5%),但可被l - NNA、蜂毒明肽和蝎毒素联合使用或40 mmol/L KCl抑制。内皮α₂ - 肾上腺素能受体的激活可诱导猪心内膜阻力动脉的内皮依赖性舒张。这种舒张部分依赖于一氧化氮,其释放似乎依赖于内皮KATP通道的激活。该机制在LVH时减弱,导致UK - 14,304依赖性舒张显著降低。